Bioxel Pharma is manufacturing the first industrial scale cGMP batch of its key intermediate for docetaxel, the active ingredient in Taxotere, a chemotherapy drug marketed by Sanofi-Aventis. “This achievement is significant for Bioxel as it demonstrates our ability to manufacture semi-synthetic taxanes using a high-efficiency patent-protected route that will allow us to meet the demands of leading pharmaceutical companies” said Pascal Delmas, president and chief executive office...